Lantian Biochemical held an extraordinary general meeting on July 28, electing the eighth board of directors. Zheng Xu was re-elected as chairman, with Cui Haifeng and Li Shaohua serving as vice chairmen. On the same day, the board appointed Li Zhilei as general manager, Tang Haijun as deputy general manager and board secretary, and Peng Zhimin as deputy general manager and chief financial officer. The following day, Xu Renshan was appointed head of the audit department. The company has reported net profit attributable to the parent company in the red for five consecutive years since 2021, and its non-recurring net profit has been negative for eight straight years. In the first half of this year, it expects a net loss attributable to the parent company of between 45 million and 75 million yuan. After acquiring a 51 percent stake in Anhui Xuge Technology New Energy in 2023, the company formed a dual-core business of pesticide chemicals and photovoltaic new energy. In 2025, the photovoltaic business contributed 77 percent of revenue. As of press time, the company's stock price stood at 4.64 yuan, down about 31 percent for the year.
Jiangsu Lanfeng Bio-chemical Co LtdCompany has reported net losses for five consecutive years and expects a net loss of 45-75 million yuan in H1 2025.